The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Sulfadimezine     4-amino-N-(4,6- dimethylpyrimidin-2...

Synonyms: Pirmazin, Primazin, Vertolan, Intradine, Mermeth, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Sulfadimidine


Psychiatry related information on Sulfadimidine


High impact information on Sulfadimidine


Chemical compound and disease context of Sulfadimidine


Biological context of Sulfadimidine


Anatomical context of Sulfadimidine


Associations of Sulfadimidine with other chemical compounds


Gene context of Sulfadimidine


Analytical, diagnostic and therapeutic context of Sulfadimidine


  1. Acetylator polymorphism in human colorectal carcinoma. Ladero, J.M., González, J.F., Benítez, J., Vargas, E., Fernández, M.J., Baki, W., Diaz-Rubio, M. Cancer Res. (1991) [Pubmed]
  2. Acetylation phenotype in colorectal carcinoma. Ilett, K.F., David, B.M., Detchon, P., Castleden, W.M., Kwa, R. Cancer Res. (1987) [Pubmed]
  3. Influence of chronic obstructive lung disease on the disposition of an acidic drug (sulfamethazine). du Souich, P., Amyot, R., Julien, M., Desjardins, R., Latour, J., Leblanc, P. Arch. Intern. Med. (1983) [Pubmed]
  4. Polymorphic acetylation of sulphamethazine in a Zimbabwe population. Nhachi, C.F. J. Med. Genet. (1988) [Pubmed]
  5. The effect of water deprivation on the pharmacokinetics of antipyrine and sulphadimidine following intravenous administration in Nubian goats. Elsheikh, H.A., Osman, I.A., Abdullah, A.S. Vet. Res. Commun. (1997) [Pubmed]
  6. The effect of food deprivation on the rate of sulfamethazine elimination in goats. Abdullah, A.S., Baggot, J.D. Vet. Res. Commun. (1988) [Pubmed]
  7. Acetylator polymorphism in Alzheimer's disease. Ladero, J.M., Barquero, M.S., Coria, F., Molina, J.A., Jiménez-Jiménez, F.J., Benítez, J. The European journal of medicine. (1993) [Pubmed]
  8. Diet, acetylator phenotype, and risk of colorectal neoplasia. Roberts-Thomson, I.C., Ryan, P., Khoo, K.K., Hart, W.J., McMichael, A.J., Butler, R.N. Lancet (1996) [Pubmed]
  9. N-acetyltransferase expression and metabolic activation of the food-derived heterocyclic amines in the human mammary gland. Sadrieh, N., Davis, C.D., Snyderwine, E.G. Cancer Res. (1996) [Pubmed]
  10. Metabolic activation and carcinogen-DNA adduct detection in human larynx. Degawa, M., Stern, S.J., Martin, M.V., Guengerich, F.P., Fu, P.P., Ilett, K.F., Kaderlik, R.K., Kadlubar, F.F. Cancer Res. (1994) [Pubmed]
  11. Acetylator phenotype in systemic lupus erythematosus. Foad, B., Litwin, A., Zimmer, H., Hess, E.V. Arthritis Rheum. (1977) [Pubmed]
  12. Acetylator phenotyping of tuberculosis patients using matrix isoniazid or sulphadimidine and its prognostic significance for treatment with several intermittent isoniazid-containing regimens. Ellard, G.A., Gammon, P.T. British journal of clinical pharmacology. (1977) [Pubmed]
  13. Use of optical biosensor technology to study immunological cross-reactivity between different sulfonamide drugs. Ahmad, A., Ramakrishnan, A., McLean, M.A., Li, D., Rock, M.T., Karim, A., Breau, A.P. Anal. Biochem. (2002) [Pubmed]
  14. Pharmacokinetics, metabolism, and renal clearance of sulfadiazine, sulfamerazine, and sulfamethazine and of their N4-acetyl and hydroxy metabolites in calves and cows. Nouws, J.F., Mevius, D., Vree, T.B., Baakman, M., Degen, M. Am. J. Vet. Res. (1988) [Pubmed]
  15. Administration of a bolus formulation of baquiloprim and sulphadimidine to calves: plasma concentration--time profiles and efficacy in suppressing experimental pneumonic pasteurellosis. Dassanayake, L., White, G. Vet. Microbiol. (1994) [Pubmed]
  16. Sulphonamides in buffaloes: effect on certain blood constituents and serum enzymes. El-Gendi, A.Y., Youssef, S.A., Atef, M., El-Sayed, M.G., Abdel Aziz, S. Clin. Exp. Pharmacol. Physiol. (1982) [Pubmed]
  17. Mechanisms of nonlinear disposition kinetics of sulfamethazine. du Souich, P., Lalka, D., Slaughter, R., Elvin, A.T., McLean, A.J. Clin. Pharmacol. Ther. (1979) [Pubmed]
  18. Polymorphic arylamine N-acetyltransferase (NAT2) genes in children with insulin-dependent diabetes mellitus. Mrozikiewicz, P.M., Drakoulis, N., Roots, I. Clin. Pharmacol. Ther. (1994) [Pubmed]
  19. Influence of double genetic polymorphism on response to sulfamethazine. Woolhouse, N.M., Atu-Taylor, L.C. Clin. Pharmacol. Ther. (1982) [Pubmed]
  20. Bratton-Marshall and liquid-chromatographic methods compared for determination of sulfamethazine acetylator status. Whelpton, R., Watkins, G., Curry, S.H. Clin. Chem. (1981) [Pubmed]
  21. N-acetyltransferase polymorphism. Comparison of phenotype and genotype in humans. Hickman, D., Sim, E. Biochem. Pharmacol. (1991) [Pubmed]
  22. Arylamine N-acetyltransferase activity in human cultured cell lines. Coroneos, E., Sim, E. Biochem. J. (1993) [Pubmed]
  23. Characterization of arylamine acetyltransferase in the rabbit eye. Campbell, D.A., Schoenwald, R.D., Duffel, M.W., Barfknecht, C.F. Invest. Ophthalmol. Vis. Sci. (1991) [Pubmed]
  24. Distribution of acetyltransferase activities in the intestines of rapid and slow acetylator rabbits. Ilett, K.F., Reeves, P.T., Minchin, R.F., Kinnear, B.F., Watson, H.F., Kadlubar, F.F. Carcinogenesis (1991) [Pubmed]
  25. The contribution of N-oxidation to the metabolism of the food-borne carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in rat hepatocytes. Turesky, R.J., Bracco-Hammer, I., Markovic, J., Richli, U., Kappeler, A.M., Welti, D.H. Chem. Res. Toxicol. (1990) [Pubmed]
  26. Acetylation phenotype is not associated with breast cancer. Ilett, K.F., Detchon, P., Ingram, D.M., Castleden, W.M. Cancer Res. (1990) [Pubmed]
  27. Acetylation phenotype, platelet monoamine oxidase inhibition, and the effectiveness of phenelzine in depression. Davidson, J., McLeod, M.N., Blum, M.R. The American journal of psychiatry. (1978) [Pubmed]
  28. Immunological evidence for N-acetyltransferase isozymes in the rabbit. Reeves, P.T., Kinnear, B.F., Minchin, R.F., Ilett, K.F. Mol. Pharmacol. (1991) [Pubmed]
  29. Determination of the acetylator phenotype and pharmacokinetics of some sulphonamides in man. Vree, T.B., O'Reilly, W.J., Hekster, Y.A., Damsma, J.E., van der Kleijn, E. Clinical pharmacokinetics. (1980) [Pubmed]
  30. Evaluation of caffeine as a test drug for CYP1A2, NAT2 and CYP2E1 phenotyping in man by in vivo versus in vitro correlations. Fuhr, U., Rost, K.L., Engelhardt, R., Sachs, M., Liermann, D., Belloc, C., Beaune, P., Janezic, S., Grant, D., Meyer, U.A., Staib, A.H. Pharmacogenetics (1996) [Pubmed]
  31. Single nucleotide polymorphisms, metabolic activation and environmental carcinogenesis: why molecular epidemiologists should think about enzyme expression. Williams, J.A. Carcinogenesis (2001) [Pubmed]
  32. Expression of cytochromes P450 and glutathione S-transferases in human prostate, and the potential for activation of heterocyclic amine carcinogens via acetyl-coA-, PAPS- and ATP-dependent pathways. Di Paolo, O.A., Teitel, C.H., Nowell, S., Coles, B.F., Kadlubar, F.F. Int. J. Cancer (2005) [Pubmed]
  33. Expression in human prostate of drug- and carcinogen-metabolizing enzymes: association with prostate cancer risk. Agúndez, J.A., Martínez, C., Olivera, M., Gallardo, L., Ladero, J.M., Rosado, C., Prados, J., Rodriguez-Molina, J., Resel, L., Benítez, J. Br. J. Cancer (1998) [Pubmed]
  34. Immunochemical, 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation. Culp, S.J., Roberts, D.W., Talaska, G., Lang, N.P., Fu, P.P., Lay, J.O., Teitel, C.H., Snawder, J.E., Von Tungeln, L.S., Kadlubar, F.F. Mutat. Res. (1997) [Pubmed]
  35. Deficiency of cytosolic arylamine N-acetylation in the domestic cat and wild felids caused by the presence of a single NAT1-like gene. Trepanier, L.A., Cribb, A.E., Spielberg, S.P., Ray, K. Pharmacogenetics (1998) [Pubmed]
  36. Inter-individual variation of human blood N-acetyltransferase activity in vitro. Lindsay, R.M., Baty, J.D. Biochem. Pharmacol. (1988) [Pubmed]
  37. Recent developments in the investigation of thyroid regulation and thyroid carcinogenesis. Hard, G.C. Environ. Health Perspect. (1998) [Pubmed]
  38. Identification and determination of sulphamethazine and N4-acetylsulphamethazine in meat by high-performance liquid chromatography with photodiode-array detection. Horie, M., Saito, K., Hoshino, Y., Nose, N., Hamada, N., Nakazawa, H. J. Chromatogr. (1990) [Pubmed]
  39. Pharmacokinetics of sulfadimidine in normal and diarrheic calves. Lapka, R., Urbanová, Z., Kobylka, B., Rasková, H., Vanĕcek, J., Polák, L. Drug Metab. Dispos. (1978) [Pubmed]
WikiGenes - Universities